Immunome, Inc. (IMNM)
NASDAQ: IMNM · Real-Time Price · USD
18.96
+0.20 (1.07%)
Oct 29, 2026, 10:31 AM EDT - Market open
Immunome Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -254.32 | -212.39 | -292.96 | -106.81 | -36.9 | -24.71 |
Depreciation & Amortization | 3.42 | 2.96 | 2.1 | 0.73 | 0.63 | 0.76 |
Loss (Gain) From Sale of Assets | 0.08 | 0.9 | - | - | - | - |
Asset Writedown & Restructuring Costs | 10 | 10 | 152.34 | 80.8 | - | - |
Loss (Gain) From Sale of Investments | -1.26 | -2.84 | -2.9 | -0.51 | - | - |
Stock-Based Compensation | 31.39 | 25.69 | 15.75 | 6.22 | 5.33 | 3.45 |
Other Operating Activities | - | - | - | - | - | -0.5 |
Change in Accounts Payable | 2.2 | -9.16 | 9.53 | -0.61 | -0.68 | 1.78 |
Change in Unearned Revenue | - | -6.94 | -9.04 | 15.98 | - | - |
Change in Other Net Operating Assets | -0.31 | 0.88 | 14.39 | -3.38 | 2.92 | 1 |
Operating Cash Flow | -208.79 | -190.92 | -110.79 | -7.57 | -28.69 | -18.23 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -10.29 | -9.69 | -7.17 | -0.83 | -0.25 | -0.08 |
Cash Acquisitions | - | - | - | 9.28 | - | - |
Sale (Purchase) of Intangibles | -9.01 | -6.25 | -46.34 | - | - | - |
Investment in Securities | -177.18 | 76.73 | -31.56 | -38.93 | - | - |
Investing Cash Flow | -196.48 | 60.8 | -85.06 | -30.48 | -0.25 | -0.08 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Repaid | - | - | - | - | - | -0.11 |
Net Debt Issued (Repaid) | - | - | - | - | - | -0.11 |
Issuance of Common Stock | 508.17 | 679.81 | 255.76 | 0.41 | 0.03 | 28.66 |
Other Financing Activities | -29.07 | -39.46 | -15.23 | 116 | - | -0.78 |
Financing Cash Flow | 479.11 | 640.36 | 240.53 | 116.41 | 0.03 | 27.77 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Cash Flow | 73.83 | 510.24 | 44.67 | 78.36 | -28.91 | 9.46 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -219.09 | -200.6 | -117.97 | -8.4 | -28.94 | -18.31 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | - | -2890.13% | -1304.80% | -59.92% | - | - |
Free Cash Flow Per Share | -2.14 | -2.30 | -2.01 | -0.42 | -2.39 | -1.59 |
Levered Free Cash Flow | -143.66 | -133.62 | -96.32 | -1.65 | -14.89 | -8.75 |
Unlevered Free Cash Flow | -143.66 | -133.62 | -96.32 | -1.65 | -14.89 | -8.74 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | - | - | - | - | - | 0.01 |
Change in Working Capital | 1.89 | -15.23 | 14.87 | 12 | 2.24 | 2.78 |